Final Program with Media

OPENING SESSION
 

Welcome: ASE Past President and Value Summit Chair, Benjamin F. Byrd III, MD, FASE

 
Value-Based Healthcare in the U.S. – A Congressional Perspective
Representative Jim Cooper (D-TN)
Rep. Cooper addressed the growth in healthcare expenditures in the US and how this impacts government-supported medical care, along with the challenges of orchestrating an effective Congressional response to the problem.
 
Value-Based Healthcare in the U.S. – A Health System Perspective
Thomas R. Graf, MD, Chief Medical Officer, Population Health and Longitudinal Health Care Services Lines, Geisinger Health System
Dr. Graf discussed how providers can successfully respond to population healthcare needs while simultaneously containing healthcare costs, with an emphasis on new delivery systems such as Accountable Care Organizations (ACOs).

Download Dr. Graf’s slides

 
WATCH VIDEO OF OPENING SESSION
PATIENT PANEL SESSION
Echo – The Patient Perspective – Moderated by Dr. Randolph P. Martin
Panelists Include: Sarah Woodruff, Heart 2 Heart Ambassador for the Adult Congenital Heart Association (ACHA); William Wallace, Executive Director of US Ignite; Alexis Isenberg, Principal and Owner of The Lexis Group, LLC; James D. Thomas, MD, FASE, FACCThe audience heard from several patients with different backgrounds, about how echo has impacted their care, both as an initial diagnostic tool as well as lifelong monitoring.

Download Dr. Thomas’ slides

WATCH VIDEO OF PATIENT PANEL SESSION

 
VALUE CHOICE SESSION
Echo: The Value Choice in Cardiac Imaging – Moderated by James D. Thomas, MD, FASE, FACC
Panelists include: Thomas J. Ryan, MD, FACC, FASE; R. Parker Ward, MD, FACC, FASE, FASNC
This panel discussed echo’s comparative value among the cardiac imaging modalities, including examples from the ACCF/AHA/ASE multi-modality AUC guidelines.
Download Dr. Ward’s slides

Download Dr. Ryan’s slides

WATCH VIDEO OF VALUE CHOICE SESSION

PAYER PERSPECTIVES SESSION
Value-Based Healthcare – The Payer Perspectives – Moderated by David H. Wiener, MD, FACC, FAHA, FASE
Panelists Include: John C. Pilotte from CMS; Amol Navathe, MD, PhD,  of Navigant Consulting, Inc.; Anthony V. Coletta, MD, MBA, President and CEO of Tandigm Health; and Susan Nedza, MD, MBA, FACEP, Chief Medical Officer, AIM Specialty Health, Inc.(a subsidiary of WellPoint) 
The transition to value-based payment systems is led by government and regulatory agents, as well as private insurers. This panel featured leaders from both payer realms, discussing the frameworks behind policies they are implementing to incentivize population health and value-based care.  The panel also explored how cardiovascular imaging may be utilized in these new payment models.
Download Dr. Coletta’s slides

Download Dr. Nedza’s slides

 

WATCH VIDEO OF PAYER PERSPECTIVES SESSION

CLINICAL VALUE SESSIONS
SESSION #1: Value of Echo in Specific Populations – Moderated by Michael H. Picard, MD, FACC, FASE, FAHA
Panelists Include: Randolph P. Martin, MD, FACC, FASE, FESC; Jack Rychik, MD, FACC;  Steven A. Goldstein, MD
This panel discussed the role of echocardiography in the management of a variety of patients, including those with cancer, fetal heart abnormalities, and complex myocardial infarction. 

Download Dr. Martin’s slides

Download Dr. Rychik’s slides

Download Dr. Goldstein’s slides

 

WATCH VIDEO OF CLINICAL VALUE SESSION #1
 
SESSION #2: Value of Echo in Clinical Cardiology – Moderated by Dr. Michael H. Picard
Panelists Include: Theodore P. Abraham, MD, FACC, FASE; Linda D. Gillam, MD, MPH, FASE; Pamela S. Douglas, MD, MACC, FASE, FAHA
This panel focused on the role of echocardiography in Heart Failure, Valvular Heart Disease, Coronary Artery Disease, and Heart Disease in Women.
Download Dr. Abraham’s slides

Download Dr. Gillam’s slides

Download Dr. Douglas’ slides

WATCH VIDEO OF CLINICAL SESSION #2

RESEARCH SESSION
The Value of Echo in Research – Moderated by Patricia A. Pellikka, MD, FACC, FACP, FAHA, FASE
Panelists include: Denis B. Buxton, PhD from the NHLBI; Pamela S. Douglas, MD, MACC, FASE, FAHA; Neil J. Weissman, MD, FACC, FASE
Research impacts patient care in a variety of ways, including clinical trials to assess new devices and pharmaceuticals, as an end-point measure in studies to determine efficacy of various treatment protocols, and through basic, applied, and translational research.  Panelists will consider echo’s role in these various research paradigms.
Download Dr. Buxton’s slides

Download Dr. Douglas’ slides

 

WATCH VIDEO OF RESEARCH SESSION

 
 
GLOBAL ECHO SESSION
Echo’s Impact: A Global Vision
Anthony J. Dean, MD, FAAEM, FACEP, Director, Division of Emergency Ultrasonography, University of Pennsylvania Medical Center
From septic shock in North America to dehydration and tuberculosis in Africa, technological advances now allow echocardiography to be utilized in the management of time-critical illnesses in resource-poor healthcare settings in both developing and industrialized countries.  The potential benefit for patients with common life-threatening conditions comes with a commensurate challenge for medical education.  This session discussed these issues, and efforts by the ASE and WINFOCUS to fill the knowledge and training gap.
Download Dr. Dean’s slides WATCH VIDEO OF GLOBAL ECHO SESSION
 
 
INTERACTIVE BREAKOUT SESSIONS
Attendees were invited to participate in interactive discussion about one of three topics.  At the end of the breakout sessions, all attendees reconvened and each breakout session moderator offered a recap of the discussions, including Q&A with the audience.

 

Group A, Patient-centered Care Moderated by Kenneth D. Horton, RCS, RDCS, FASE of Intermountain Heart Institute and Joseph Kreeger, RCCS, RDCS, FASE of Children’s Healthcare of Atlanta

Topics:  An Institute for Healthcare Improvement panel recently called on physicians not only to discuss treatment options with patients but also to promote greater cost transparency and information on the value of treatment options.  This group discussed this type of request and also best ways to dialogue with patients about the value of CV Imaging, radiation safety, and the Choosing Wisely® campaign and its emphasis and impact on the relationship of the provider and patient.

 

Group B, Improving Quality & Access of Echo

Moderated by : Partho P. Sengupta, MBBS, MD, DM, FASE of Mount Sinai Medical Center

Topics: There have many articles in the news related to the poor state of access to quality healthcare in the U.S.  This group discussed best ways to create an environment that promotes adherence to quality metrics and access to excellent patient care specific to CV imaging.

 

Group C, New Technologies in Echo

Moderated by: Allan L. Klein, MD, FACC, FASE of Cleveland Clinic

Topics:  Technology and its impact on the world of medicine have been rapidly changing patient care.  This group discussed the expansion of “smart” devices that help the provider to make correct measurements, the expansion of apps and wearables to assist practice, cutting-edge echo techniques such as Strain and 3D, and other new uses for CV ultrasound such as its aid as a therapeutic tool.

 

 

WATCH VIDEO OF BREAKOUT SESSION DISCUSSION RECAP